Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minocycline and Aspirin in Bipolar Depression
NCT01429272Phase 3Completed
- Start
- Sep 2011
- Primary completion
- Aug 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in bipolar disorder (BD) comparing Placebo & Placebo with minocycline & aspirin (2 arms). Primary endpoint: Treatment Response at 6 weeks. Started Sep 2011; status: completed.
02
Drugs
minocyclineaspirin
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT01429272.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01429272.